AbCellera Biologics Inc. ABCL Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s stock-based comp?
- AbCellera Biologics Inc. (ABCL) reported stock-based comp of $2.97M in Q4 2025.
- What does stock-based comp mean?
- Represents the dollar amount of share-based compensation expenses that are not deductible for income tax purposes. This item is a common reconciling factor between book income and taxable income, impacting the effective tax rate.